## Pathophysiology of Hyperkalemia in Lupus Nephritis with CKD ### Primary Mechanism: Reduced GFR and Impaired Urinary K⁺ Excretion This patient with stage IV lupus nephritis and an eGFR of 28 mL/min/1.73 m² has **chronic kidney disease (CKD Stage 3b)** as the **PRIMARY underlying mechanism** of hyperkalemia. The question asks for the PRIMARY *underlying* mechanism — not the acute precipitant. | Factor | Mechanism | Role in This Case | |--------|-----------|-------------------| | **Reduced GFR (eGFR 28)** | Impaired urinary K⁺ excretion | **PRIMARY — fundamental, underlying** | | **Metabolic Acidosis (pH 7.28)** | Transcellular K⁺ shift (H⁺ in, K⁺ out) | **Contributing — acute amplifier** | | **Lupus nephritis** | Glomerular/tubular damage → reduced nephron mass | **Structural basis for reduced GFR** | ### Why Reduced GFR Is the PRIMARY Underlying Mechanism **Key Point:** The kidneys are responsible for excreting ~90% of daily dietary potassium. In CKD, as the GFR falls below 30 mL/min, the remaining nephrons cannot adequately excrete the daily K⁺ load, leading to progressive positive K⁺ balance and hyperkalemia. - With eGFR 28, the patient has lost >70% of functional nephron mass - Reduced distal tubular flow and impaired aldosterone responsiveness in CKD further limit K⁺ secretion - This is the **structural, irreversible, and foundational** cause of hyperkalemia in this patient Per **Harrison's Principles of Internal Medicine (21e, Ch. 280):** "Hyperkalemia in CKD results primarily from reduced urinary potassium excretion due to decreased GFR and impaired distal tubular secretion." Metabolic acidosis is listed as a *contributing* factor, not the primary mechanism. ### The Role of Metabolic Acidosis (Option B) **Clinical Pearl:** While metabolic acidosis does cause transcellular K⁺ shift (for every 0.1 unit ↓ in pH, serum K⁺ rises ~0.6 mEq/L), this is an **acute amplifier** superimposed on the chronic underlying defect. Acidosis alone in a patient with normal renal function would be rapidly corrected by increased urinary K⁺ excretion — this patient cannot do so because of her reduced GFR. Furthermore, the acidosis itself in this patient is largely a consequence of CKD (reduced acid excretion → metabolic acidosis), making reduced GFR the more fundamental upstream mechanism. ### Why Other Options Are Incorrect - **Option C (Lupus-mediated collecting duct destruction):** Lupus nephritis primarily causes glomerular injury (class IV = diffuse proliferative GN), not selective collecting duct epithelial destruction. This is not a recognized mechanism of lupus-induced hyperkalemia. - **Option D (MMF-induced hypoaldosteronism):** Mycophenolate mofetil is not associated with hypoaldosteronism. This is a distractor; calcineurin inhibitors (tacrolimus, cyclosporine) can cause hyperkalemia via hypoaldosteronism, but not MMF. ### Management Implications 1. **Stabilize cardiac membrane:** Calcium gluconate IV (ECG changes present) 2. **Shift K⁺ intracellularly:** Insulin + dextrose; sodium bicarbonate (also corrects acidosis) 3. **Remove K⁺:** Sodium zirconium cyclosilicate / patiromer (chronic); dialysis if refractory 4. **Address underlying CKD:** Nephrology referral, optimize lupus nephritis treatment **High-Yield:** In CKD-associated hyperkalemia, reduced GFR is the PRIMARY underlying mechanism. Metabolic acidosis, hypoaldosteronism, and dietary excess are *contributing* factors that worsen hyperkalemia in the setting of already-impaired renal K⁺ excretion. [cite: Harrison 21e Ch. 280; Brenner & Rector's The Kidney, 11e Ch. 17]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.